Karen Charlton
Medical · Germantown, TNNPI 1073581823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 40.4% of the total.
Across 102 payments — averaging $46.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$506
- Amgen$492
- Lilly USA, LLC$475
- GSK$315
- AbbVie$259
- plus $797 from 14 others
What the payments were for
- Food & beverage$4,765100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $1,930 |
| Novo Nordisk | 18 | $506 |
| Amgen | 5 | $492 |
| Lilly USA, LLC | 6 | $475 |
| GSK | 11 | $315 |
| AbbVie | 6 | $259 |
| Bayer | 3 | $254 |
| Dexcom, Inc. | 2 | $113 |
| Merck | 2 | $112 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Phathom Pharmaceuticals, Inc. | 5 | $40 |
| Corcept Therapeutics | 2 | $40 |
| Boehringer Ingelheim | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Abbott | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Seqirus USA Inc | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,774 in reported general payments places this provider in the 85th percentile of 480 medical providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 13 | $29,265 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $17,546 |
| FarxigaDapagliflozin Propanediol | 12 | $15,475 |
| JardianceEmpagliflozin | 13 | $13,012 |
| EliquisApixaban | 18 | $11,664 |
| Gabapentin | 48 | $818 |
| Atorvastatin Calcium | 61 | $745 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $558 |
| Amlodipine Besylate | 58 | $466 |
| Rosuvastatin Calcium | 40 | $442 |
| Tamsulosin Hcl | 29 | $408 |
| Montelukast Sodium | 29 | $405 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $376 |
| Metformin Hcl | 39 | $372 |
| Diclofenac Sodium | 23 | $354 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $475 | $29,26513 claims |
| GSKTrelegy Ellipta | $315 | $17,54619 claims |
| AstraZenecaFarxiga | $1,930 | $15,47512 claims |
| Boehringer IngelheimJardiance | $34 | $13,01213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 480 medical providers in Tennessee.
Other medical in Germantown
- Shelley MulrooneyGermantown$6K
- Maria WoodChattanooga$130K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
- Evan HatfillNashville$18K
- Meredith McDanielChattanooga$17K
- Janet BreedingKnoxville$15K
- Paul MabenKnoxville$13K
- Hannah KirkGreeneville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.